Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,837 | -7,160 | -6,320 | -3,453 | -19,266 |
| Depreciation Amortization | 984 | 603 | 412 | 217 | 697 |
| Accounts receivable | -327 | -1,084 | 660 | -1,023 | -642 |
| Other Working Capital | -758 | -363 | 2,325 | -1,857 | -1,452 |
| Other Operating Activity | 2,325 | 3,449 | 1,652 | 2,907 | 3,905 |
| Operating Cash Flow | $-5,613 | $-4,556 | $-1,271 | $-3,209 | $-16,759 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -708 | -546 | -317 | -236 | -698 |
| Purchase Sale Intangibles | -968 | -864 | -689 | -273 | -822 |
| Other Investing Activity | -968 | -864 | -689 | -273 | -822 |
| Investing Cash Flow | $-1,676 | $-1,410 | $-1,006 | $-509 | $-1,520 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,411 | 1,411 | 1,411 | N/A | 5,000 |
| Debt Repayment | -16,411 | -1,411 | -1,411 | N/A | N/A |
| Common Stock Issued | 1,509 | 1,282 | 1,103 | 138 | 2,508 |
| Other Financing Activity | 79,839 | 80,214 | 24,013 | 17,743 | 670 |
| Financing Cash Flow | $66,348 | $81,496 | $25,115 | $17,882 | $8,178 |
| Exchange Rate Effect | 130 | 215 | 43 | -7 | -35 |
| Beginning Cash Position | 12,232 | 12,232 | 12,232 | 12,232 | 22,369 |
| End Cash Position | 71,422 | 87,978 | 35,114 | 26,389 | 12,232 |
| Net Cash Flow | $59,189 | $75,746 | $22,882 | $14,157 | $-10,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,613 | -4,556 | -1,271 | -3,209 | -16,759 |
| Capital Expenditure | -708 | -546 | -317 | -236 | -698 |
| Free Cash Flow | -6,322 | -5,102 | -1,588 | -3,445 | -17,457 |